CClinicalTrials.gg
Status unknownNCT03731949Updated Jan 10, 2019

Placental Volume Analysis During Pregnanay

An observational study in Placenta Diseases, sponsored by Aljazeera Hospital. Status unknown at 1 site in Egypt. Open to female participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-10.

Sponsored by Aljazeera Hospital · Observational

The sponsor has not verified this record recently (last verified Jan 2019), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
500
Ages
20 Years to 40 Years
Sex
Female
01

Study summary

Placenta grows with advancing gestational age amonitoring of placental growth is important in pregnancy evaluation

Read the detailed description

assessment of placental size is very important in evaluating the pregnancy Placenta is one of the most important organs that control pregnancy outcome

02

Conditions studied

  • Placenta Diseases

Browse trials for

03

In context

Placenta Diseases

24 studies on the registry are indexed under Placenta Diseases; 6 are open to participants now.

This study's planned enrollment of 500 is above the median of 120 across 21 observational studies indexed under Placenta Diseases.

Browse Placenta Diseases studies →

Lead sponsor

Aljazeera Hospital is the lead sponsor of 63 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

  • pregnant ladies between 20 - 40 years old
  • ladies pregnant from 14 weeks till term

Inclusion criteria

  • pregnant ladies between 20 - 40 years old
  • ladies pregnant from 14 weeks till term

Exclusion criteria

Exclusion Criteria:

  • pregnant ladies in first trimester
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
500 participants (estimated)
Target follow-up
4 Months
Patient registry
Yes

Interventions

  • Diagnostic testUltrasonography

    Ultrasonography to assess placental volume

06

What researchers measure

Primary outcomes

  1. the volume of every placenta at the given time of scan

    volume of placenta that will increase with time

    Time frame: within 2 months

07

Study locations

1 of 1 sites recruiting
  • Algazeerah and Kasralainy hospital
    Giza, Egypt
    • Mahmoud Alalfy, master · Contact · mahmoudalalfy@ymail.com · +201002611058
    • Ahmed Elgazzar, M.D · Contact · +201014005959
    • Mahmoud Alalfy, master · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 10, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03731949
Lead sponsor
Aljazeera Hospital
Collaborators
Kasr El Aini Hospital, National Research Centre, Egypt
Responsible party
Mahmoud Alalfy (Lecturer, Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital, Aljazeera Hospital) — Principal investigator
First posted
Nov 6, 2018
Start date
Nov 16, 2018
Primary completion
Jun 1, 2019 (estimated)
Completion
Jul 5, 2019 (estimated)
Last update
Jan 10, 2019

Study contacts

Mahmoud Alalfy
Contact
mahmoudalalfy@ymail.com
01002611058
Mahmoud Alalfy
principal investigator · Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion